Wednesday, November 27, 2019 12:24 AM
and the Vision Impact Institute
(VII) have announced their support of a social media campaign promoting the right of women throughout the world to wear eyeglasses. The campaign is based around a series of hashtags including #glasses4women that have been trending on Twitter since early November. The hashtags sprang up in reaction to recent reports
aired by Japan’s Nippon TV and Business Insider Japan that revealed that women in Japan working in a number of industries have been instructed by the companies in which they work to refrain from wearing eyeglasses on the job. The same rules do not apply to their male counterparts. Reasons given for the policy range from appearance to safety.
Wednesday, November 20, 2019 12:24 AM
DURHAM, N.C.—Aerie Pharmaceuticals
(NASDAQ:AERI) announced the signing of an agreement to acquire Avizorex Pharma
(AVX), a Spanish ophthalmic pharmaceutical company developing therapeutics for the treatment of dry eye disease. “This acquisition bolsters our pipeline with a clinical-stage dry eye product candidate, and we are excited to expand our footprint in ophthalmology. This product has a novel mechanism-of-action for treating dry eye and we believe that, if approved, it could nicely complement the currently approved drugs for this indication. Since the majority of our efforts in 2020 will be focused on supportive non-clinical studies, we do not currently expect to meaningfully increase our R&D expenditures next year,” said Vicente Anido, Jr., PhD, chairman and chief executive officer at Aerie.
Monday, November 18, 2019 12:21 AM
, a supplier of vision wellness devices, has been honored with a CES 2020 Innovation Award for its EyeQue Vision Monitoring Kit
, a convenient, low-cost eye wellness system designed for everyone from children to adults. EyeQue will feature the system at CES 2020
, the mega technology exhibition which will take place in Las Vegas from January 7-10, 2020. This is the company’s third CES Innovation Award in the last four years and its second in the category of “Tech for a Better World.”
Monday, November 18, 2019 12:18 AM
TUCSON, Ariz.—Scientists in the University of Arizona Department of Physiology
have identified a potential molecular mechanism that may hold the key to understanding how pressure is regulated in the eye. Funded by a $2.3 million five-year grant from the National Institutes of Health (NIH) National Eye Institute
, this research could help to develop future treatments for glaucoma and other diseases. Current treatments focus on lowering eye pressure with eyedrops and oral medications. However, these drugs lose their effectiveness over time. More than three million Americans suffer from glaucoma, the second-leading cause of blindness in the U.S., according to Prevent Blindness America
Friday, November 15, 2019 12:21 AM
HARRISBURG, Pa.—MacuLogix Inc.
, a company that equips eyecare professionals with instruments, tools and education to effectively diagnose and treat patients with age-related macular degeneration (AMD), appointed Christine Silverberg, MBA, BSN, RN, as director of national accounts. In this role, Silverberg will lead business development and partnerships across the industry to make “dark adaptation” testing more readily available to consumers across the U.S., according to an announcement earlier this week. “Christine brings a depth and breadth of experience calling on the C-Suites of major independent delivery networks and accountable care organizations in the U.S.,” president and chief executive officer William McPhee said in the announcement. “Her knowledge of population health, business operations and data analytics to execute successful programs in corporate settings will be invaluable in supporting our mission.”
Wednesday, November 13, 2019 12:18 AM
ST. LOUIS—Citing the significant public and economic burden posed by diabetes in the United States, the American Optometric Association
(AOA) has issued its revised, evidence-based clinical practice guideline on the disease for doctors of optometry and other health professionals who deliver care to patients with diabetes.
Tuesday, November 12, 2019 12:21 AM
BEDFORD, Mass.—Ocular Therapeutix Inc.
(NASDAQ: OCUL), a biopharmaceutical company focused on developing and commercializing innovative therapies for diseases and conditions of the eye, announced an operational restructuring plan. Upon its completion, the plan is expected to result in an estimated $11 million in annualized savings through personnel reductions and approximately $14 million in one-time program deferrals. The company estimates that it will record costs associated with the restructuring of approximately $0.7 million in the fourth quarter, according to its announcement.
Monday, November 11, 2019 12:45 AM
NEW YORK—Did you know that more than 2,000 people injure their eyes at work every day? And of these injuries, an estimated 10 percent to 20 percent will cause temporary or permanent vision loss, Prevent Blindness points out. The National Institute for Occupational Safety and Health (NIOSH) believes that the right eye protection can lessen the severity of those injuries and even prevent 90 percent of them.
Monday, November 11, 2019 12:30 AM
NEW YORK—We are living in an age of specialization. Today we can get virtually anything we want from a business whose only business is delivering a certain type of product or service, whether it’s a vegan restaurant or Victoria’s Secret. Optometry, like many medical professions, is being reshaped by the specialization trend. Modern living has changed the way we use our eyes, and many optometrists, particularly those in private practice, have responded by developing specialties to address specific patient needs. Some specialties, such as pediatrics and low vision, have been long established in optometry, while others, like dry eye management and neuro-optometry are more recent additions. Yet all seem to be benefitting from the advent of new technologies and treatment methods which are bringing exciting changes to vision care.